HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Venus embraces country phenom

This article was originally published in The Rose Sheet

Executive Summary

Newly deified "Goddess of Summer" Taylor Swift will share her summer beauty secrets with fans on the Venus Embrace Web site beginning Aug. 15, according to July 29 release. Triple-platinum teenage country music phenomenon - the youngest person ever to write and sing a No. 1 country single with "Our Song," which spent 6 consecutive weeks at top of Billboard's Country Singles Chart, firm notes - was brought to Venus' attention during the Country Music Television Awards. "When Venus Embrace noticed a talented, charismatic and barefoot Taylor Swift nabbing top prizes ... they knew that they were watching a Goddess in the making." Touted as "the most advanced female shaving system ever," Venus Embrace boasts five blades surrounded by a protective moisture ribbon (1"The Rose Sheet" March 3, 2008, p. 5)...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015602

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel